Whilst this study suggests urinary uromodulin may have utility in clinical practice in hypertensive pregnancy, future research is needed to determine to what extent uromodulin can be used as a clinical biomarker for renal adaptation and renal function during pregnancy and post-partum CKD risk in high-risk women. This evidence concerns the gene UMOD and chronic kidney disease.